Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Griffith

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Annals of the American Thoracic Society|September 15, 2016
Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop ReportEmily Henkle, Timothy Aksamit, Alan Barker, et al.
Chest|November 28, 2016
Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research RegistryTimothy R Aksamit, Anne E O'Donnell, Alan Barker, et al.
Annals of the American Thoracic Society|January 19, 2018
The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis BronchiectasisMark L Metersky, Timothy R Aksamit, Alan Barker, et al.
Journal of the Intensive Care Society|November 17, 2025
Anaemia management with red blood cell transfusion to improve post-intensive care disability: Protocol for the ABC post-ICU randomised controlled trialTimothy S Walsh, Lydia Emerson, Jo Singleton, et al.
The Journal of Biological Chemistry|November 15, 2025
Discovery of small molecule modulators of the thin filament that alter the contractile profile in a hypertrophic cardiomyopathy engineered tissue modelRuth F Sommese, Samuel M Levi, Janice Brown, et al.
American Journal of Respiratory and Critical Care Medicine|March 9, 2019
IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses <i>In Vivo</i>Alison J Harris, Ananda S Mirchandani, Ruairi W Lynch, et al.
JAMA|February 28, 2018
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical TrialKeith S Kaye, Tanaya Bhowmick, Symeon Metallidis, et al.
Infectious Diseases and Therapy|October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialRichard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Wellcome Open Research|May 28, 2021
-------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--Leila Reyes, Manuel A Sanchez-Garcia, Tyler Morrison, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysisFederica Fregonese, Shama D Ahuja, Onno W Akkerman, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Annals of the American Thoracic Society|September 15, 2016
Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop ReportEmily Henkle, Timothy Aksamit, Alan Barker, et al.
Chest|November 28, 2016
Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research RegistryTimothy R Aksamit, Anne E O'Donnell, Alan Barker, et al.
Annals of the American Thoracic Society|January 19, 2018
The Prevalence and Significance of Staphylococcus aureus in Patients with Non-Cystic Fibrosis BronchiectasisMark L Metersky, Timothy R Aksamit, Alan Barker, et al.
Journal of the Intensive Care Society|November 17, 2025
Anaemia management with red blood cell transfusion to improve post-intensive care disability: Protocol for the ABC post-ICU randomised controlled trialTimothy S Walsh, Lydia Emerson, Jo Singleton, et al.
The Journal of Biological Chemistry|November 15, 2025
Discovery of small molecule modulators of the thin filament that alter the contractile profile in a hypertrophic cardiomyopathy engineered tissue modelRuth F Sommese, Samuel M Levi, Janice Brown, et al.
American Journal of Respiratory and Critical Care Medicine|March 9, 2019
IL4Rα Signaling Abrogates Hypoxic Neutrophil Survival and Limits Acute Lung Injury Responses <i>In Vivo</i>Alison J Harris, Ananda S Mirchandani, Ruairi W Lynch, et al.
JAMA|February 28, 2018
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical TrialKeith S Kaye, Tanaya Bhowmick, Symeon Metallidis, et al.
Infectious Diseases and Therapy|October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialRichard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Wellcome Open Research|May 28, 2021
-------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--Leila Reyes, Manuel A Sanchez-Garcia, Tyler Morrison, et al.
The Lancet. Respiratory Medicine|March 30, 2018
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysisFederica Fregonese, Shama D Ahuja, Onno W Akkerman, et al.
Pageof 7